RESUMEN

Las dermatosis perforantes (DP) o enfermedades por eliminación transepidérmica son un grupo de entidades caracterizadas por la extrusión de material dérmico alterado a través de la epidermis que incluye a la colagenosis perforante reactiva, la elastolisis perforante serpiginosa, la foliculitis perforante y la enfermedad de Kyrle. Se caracterizan por la aparición de pápulo-nódulos centrados por tapones o costras queratósicas, pruriginosos. Entre las opciones terapéuticas se describen los antihistamínicos, fototerapia y corticoides intralesionales, con resultados variables. Objetivos. Describir 8 casos de dermatosis perforante diagnosticados en nuestro servicio. Materiales y Métodos. Se realizó un estudio retrospectivo, observacional y descriptivo que evaluó las características clínicas, histológicas y la asociación con patología sistémica de los pacientes con diagnóstico histológico de dermatosis perforante que concurrieron a nuestro servicio entre septiembre de 2006 y julio de 2010.Resultados. Se diagnosticaron 8 pacientes con dermatosis perforante. Del total, 5 (62,5%) fueron hombres y 3 mujeres (37,5%). La edad media de presentación fue de 57,12 años (37-71 años); 6 (75%) correspondían a enfermedad de Kyrle y 2 (25%) a foliculitis perforante; 6 (75%) se asociaban a insuficiencia renal crónica, 6 (75%) a diabetes mellitus, 1 (12,5%) a insuficiencia renal aguda y 6 (75%) a enfermedad cardiovascular. Conclusiones. Si bien la mayoría de nuestros pacientes tenían antecedentes de diabetes y/o insuficiencia renal crónica como se describe en la literatura, cabe destacar que en uno de ellos no se encontró ninguna de estas asociaciones. Adicionalmente, el 75% de los pacientes tenía antecedentes de enfermedad cardiovascular. Encontramos una mayor incidencia en hombres (62,5%) a diferencia de lo reportado en algunos trabajos (AU)

---

Perforating dermatosis (DP) comprises a group of diseases characterized by the extrusion of dermic debris through the epidermis. It includes reactive perforating collagenosis, perforating folliculitis, elastosis perforans serpiginosa and Kyrle's disease. It presents as multiple pruritic papulo nodules centered by a keratotic plug. Antihistamines, phototherapy and intralesional steroids are among the therapeutic options described, with variable results. Objectives. To describe 8 cases of perforating dermatosis diagnosed in our department. Materials and Methods. We conducted a retrospective, observational and descriptive study evaluating clinical and histological features and association with systemic disease, of the patients with a biopsy confirmed, perforating dermatosis between September 2006 and July 2010. Results. Eight patients with perforating dermatosis were diagnosed. Of them, 5 (62,5%) were male and 3 female (37,5%). Mean age of presentation was 57,12 years (37-71 years); 6 (75%) corresponded to Kyrle's disease and 2 (25%) to perforating folliculitis; 6 (75%) were associated with chronic renal insufficiency, 6 (75%) with diabetes mellitus, 1 (12,5%) with acute renal insufficiency and 6 (75%) with cardiovascular disease. Conclusions. Although most of our patients had a history of chronic renal insufficiency or diabetes, as described in the literature, in one of them no associated disease was found. Furthermore, 75% of the patients presented with cardiovascular disease. Unlike previous reports, we found agreater incidence in men (62,5%) over women (AU)

Asunto(s)

Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Dermatitis/diagnóstico , Foliculitis/complicaciones , Enfermedades Cutáneas Papuloescamosas/diagnóstico , Estudios Retrospectivos , Lesión Renal Aguda/complicaciones , Enfermedades Cardiovasculares/complicaciones

RESUMEN

Coronary heart disease is a prevalent condition and a leading cause of death in developed countries. Most cases are due to the cluster of classical risk factors, such as smoking, diabetes, high blood pressure and dyslipidaemia. However, a few patients develop severe and premature arteriosclerosis in spite of absence of common risk factors. Here, we present the clinical, analytical and molecular features of a 36-years-old man who died from advanced ischaemic heart disease as a result of cerebrotendinous xanthomatosis (CTX), a rare condition characterized by elevation in plasma and most tissues of cholestanol and where neurological impairment is the hallmark of this disease. We discuss the relevance of heart disease and the mechanism leading to accelerate arteriosclerosis is CTX.

Asunto(s)

Enfermedad Coronaria/complicaciones , Xantomatosis Cerebrotendinosa/complicaciones , Adulto , Enfermedad Coronaria/patología , Salud de la Familia , Resultado Fatal , Humanos , Rodilla , Masculino , Mutación/genética , Piel/patología , Xantomatosis Cerebrotendinosa/genética , Xantomatosis Cerebrotendinosa/patología

RESUMEN

Cerebrotendinous xanthomatosis (CTX) is a rare recessive autosomal disease caused by mutations of the sterol 27-hydroxylase gene. Clinically, CTX is characterized by tendon xanthomas, cataracts and progressive neurological deficits. Because of the disruption of the 27-hydroxylase activity, CTX patients have elevated plasma levels of cholestanol, a by-product of abnormal bile acid synthesis. The present authors describe a female patient with CTX. The proband in this study presented with elevated cholestanol levels, markedly reduced mitochondrial 27-hydroxylase activity and altered bile acid composition. The 27-hydroxylase gene was analysed for mutations by polymerase chain reaction amplification of the exons and the splice-junction regions of the gene. The proband was found to be a compound heterozygote for two different mutations which have not been previously described: (1) a G --> A transition at nucleotide 455 that is responsible for converting a glycine to a glutamic acid residue at amino acid position 112 (G112E); and (2) a five-nucleotide deletion in exon 5 (from nucleotide 965 to 969) that is responsible for a shift in the reading frame and the insertion of a premature codon at position 296, and consequently, the synthesis of a truncated protein lacking the heme-binding and andrenodoxin-binding domains. Long-term (18-year) treatment of the proband with chenodeoxycholic acid (750 mg day-1) has been effective in preventing any progression of the disease.

Asunto(s)

Mutación , Esteroide Hidroxilasas/genética , Xantomatosis Cerebrotendinosa/genética , Sustitución de Aminoácidos , Bilis/metabolismo , Ácidos y Sales Biliares/metabolismo , Ácidos y Sales Biliares/orina , Colestanotriol 26-Monooxigenasa , Colestanol/sangre , Colestanoles/orina , Colesterol/sangre , Femenino , Humanos , Persona de Mediana Edad , Mutación Missense , Xantomatosis Cerebrotendinosa/enzimología

Asunto(s)

Sistema Enzimático del Citocromo P-450/genética , Mutación Missense , Trastornos Parkinsonianos/genética , Esteroide Hidroxilasas/genética , Xantomatosis Cerebrotendinosa/genética , Southern Blotting , Colestanotriol 26-Monooxigenasa , Homocigoto , Humanos , Errores Innatos del Metabolismo Lipídico/genética , Masculino , Persona de Mediana Edad , Trastornos Parkinsonianos/enzimología , Polimorfismo Conformacional Retorcido-Simple , Xantomatosis Cerebrotendinosa/complicaciones , Xantomatosis Cerebrotendinosa/enzimología

RESUMEN

One of the genetic features of the Sardinian population is the high prevalence of hemoglobin disorders. It has been estimated that 13% to 33% of Sardinians carry a mutant allele of the alpha-globin gene (alpha-thalassemia trait) and that 6% to 17% are beta-thalassemia carriers. In this population, a single mutation of beta-globin gene (Q39X, beta(0) 39) accounts for >95% of beta-thalassemia cases. Because previous studies have shown that Sardinian beta-thalassemia carriers have lower total and low density lipoprotein (LDL) cholesterol than noncarriers, we wondered whether this LDL-lowering effect of the beta-thalassemia trait was also present in subjects with familial hypercholesterolemia (FH). In a group of 63 Sardinian patients with the clinical diagnosis of FH, we identified 21 unrelated probands carrying 7 different mutations of the LDL receptor gene, 2 already known (313+1 g>a and C95R) and 5 not previously reported (D118N, C255W, A378T, T413R, and Fs572). The 313+1 g>a and Fs572 mutations were found in several families. In cluster Fs572, the plasma LDL cholesterol level was 5.76+/-1.08 mmol/L in subjects with beta(0)-thalassemia trait and 8.25+/-1.66 mmol/L in subjects without this trait (P<0.001). This LDL-lowering effect was confirmed in an FH heterozygote of the same cluster who had beta(0)-thalassemia major and whose LDL cholesterol level was below the 50th percentile of the distribution in the normal Sardinian population. The hypocholesterolemic effect of beta(0)-thalassemia trait emerged also when we pooled the data from all FH subjects with and without beta(0)-thalassemia trait, regardless of the type of mutation in the LDL receptor gene. The LDL-lowering effect of beta(0)-thalassemia may be related to (1) the mild erythroid hyperplasia, which would increase the LDL removal by the bone marrow, and (2) the chronic activation of the monocyte-macrophage system, causing an increased secretion of some cytokines (interleukin-1, interleukin-6, and tumor necrosis factor-alpha) known to affect the hepatic secretion and the receptor-mediated removal of apolipoprotein B-containing lipoproteins. The observation that our FH subjects with beta(0)-thalassemia trait (compared with noncarriers) have an increase of blood reticulocytes (40%) and plasma levels of interleukin-6 (+60%) supports these hypotheses. The lifelong LDL-lowering effect of beta(0)-thalassemia trait might slow the development and progression of coronary atherosclerosis in FH.

Asunto(s)

Hiperlipoproteinemia Tipo II/complicaciones , Hiperlipoproteinemia Tipo II/genética , Talasemia beta/complicaciones , Talasemia beta/genética , Adolescente , Adulto , Secuencia de Bases , Citocinas/sangre , Cartilla de ADN/genética , Femenino , Globinas/genética , Haplotipos , Heterocigoto , Humanos , Hiperlipoproteinemia Tipo II/sangre , Italia , Lipoproteínas LDL/sangre , Activación de Macrófagos , Masculino , Mutación , Fenotipo , Receptores de LDL/genética , Talasemia beta/sangre

RESUMEN

The aim of this study was the characterization of mutations of the LDL receptor gene in 39 Italian patients with homozygous familial hypercholesterolemia, who were examined during the period 1994 to 1996. The age of the patients ranged from 1 to 64 years; one third of them were older than 30. Plasma LDL cholesterol level ranged from 10.8 to 25.1 mmol/L. The residual LDL receptor activity, measured in cultured fibroblasts of 32 patients, varied from <2% to 30% of normal and was inversely correlated with the plasma LDL cholesterol level (r=-0.665; P<0.003). The most severe coronary atherosclerosis was observed in those patients with the lowest residual LDL receptor activity (

Asunto(s)

Homocigoto , Hiperlipoproteinemia Tipo II/genética , Mutación/genética , Receptores de LDL/genética , Adolescente , Adulto , Secuencia de Aminoácidos/genética , Secuencia de Bases/genética , Niño , Preescolar , ADN Recombinante , Femenino , Haplotipos/genética , Heterocigoto , Humanos , Lactante , Italia , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , ARN Mensajero/genética

RESUMEN

Two novel mutations of the low density lipoprotein (LDL)-receptor gene were found in two Italian familial hypercholesterolemia (FH)-heterozygotes. The first mutation was an 18 nucleotide duplication in exon 8 which is preceded by an A-->T transversion. The translation product of the mutant allele was predicted to be a receptor with an in-frame insertion of 6 amino acids in repeat B of the epidermal growth factor precursor homology domain. Analysis of LDL-receptor activity in the proband's fibroblasts showed a 50% reduction of 125I-labeled LDL binding and pulse-chase studies suggested that little, if any, of the mutant protein was processed to the mature form. The second mutation was a 7 kb duplication (from intron 2 to intron 6) of exons 3 through 6, predicted to encode an elongated receptor with the duplication of repeats 2-7 of the ligand binding domain. The elongated receptor was processed slightly more slowly than the normal receptor, but was converted to a mature form of the expected size. This mature, mutant receptor was degraded more rapidly than the normal receptor. On ligand blotting the elongated receptor bound twice as much LDL or beta-very low density lipoprotein (betaVLDL) as the normal receptor. In contrast, maximum binding of LDL to proband's cells was decreased to approximately 70% of the normal cells with a significant increase in apparent affinity. Cell association at 37 degrees C, internalization, and degradation showed a similar reduced maximum. Thus these mutations demonstrate that duplications of amino acid sequences in the low density lipoprotein LDL-receptor may disrupt the LDL-receptor pathway at different levels.

Asunto(s)

Elementos Transponibles de ADN , Hipercolesterolemia/genética , Familia de Multigenes , Mutación Puntual , Receptores de LDL/genética , Receptores de LDL/metabolismo , Adulto , Secuencia de Aminoácidos , Secuencia de Bases , Membrana Celular/metabolismo , Receptores ErbB/genética , Exones , Femenino , Heterocigoto , Humanos , Cinética , Masculino , Persona de Mediana Edad , Núcleo Familiar , Reacción en Cadena de la Polimerasa , Biosíntesis de Proteínas , Secuencias Repetitivas de Ácidos Nucleicos , Mapeo Restrictivo , Dominios Homologos src

RESUMEN

We report the characterization of eight mutations of sterol 27-hydroxylase gene (CYP27) in five Italian patients with cerebrotendinous xanthomatosis, who were found to be compound heterozygotes. Four mutations (C --> T at nt 45 of exon 4, G(+1) --> A in intron 6, G(+5) --> T in intron 7, and G(-1) --> A in intron 7) are novel. The C --> T at nt 45 of exon 4 converts the arginine codon into a stop codon thus generating a truncated protein of 198 amino acids. The three splice site mutations reduced the content of CYP27 mRNA in skin fibroblasts to very low or undetectable levels and generated minute amounts of abnormal mRNAs. The G(+1) --> A transition in intron 6 produced three abnormal mRNAs. In the first, the 5' half of exon 6 joins to exon 7, skipping 89 bp of exon 6, and in the second, exon 5 joins directly to exon 7. The predicted translation products of these mRNAs are truncated proteins. In the third abnormal mRNA, exon 5 joins to exon 8 with an in-frame deletion of 246 bp. The G(+5) --> T transversion in intron 7 generates a single abnormal mRNA in which exon 6 joins directly to exon 8, with a frameshift and a premature stop codon. In the G(-1) --> A transition in intron 7, two mRNAs are generated. In the first, the retention of the whole intron 7 causes a frameshift and a premature stop codon; in the second, the joining of exon 7 to exon 8 is associated with an in-frame deletion of the first 6 nucleotides. All these novel mutations are predicted to produce structurally abnormal enzymatic proteins with no measurable biological activity.

Asunto(s)

Sistema Enzimático del Citocromo P-450/genética , Mutación , Esteroide Hidroxilasas/genética , Xantomatosis Cerebrotendinosa/genética , Adulto , Northern Blotting , Southern Blotting , Colestanotriol 26-Monooxigenasa , Sistema Enzimático del Citocromo P-450/química , Sistema Enzimático del Citocromo P-450/metabolismo , Análisis Mutacional de ADN , Femenino , Fibroblastos , Heterocigoto , Humanos , Italia , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Biosíntesis de Proteínas , Empalme del ARN , ARN Mensajero/genética , ARN Mensajero/metabolismo , Análisis de Secuencia de ADN , Esteroide Hidroxilasas/química , Esteroide Hidroxilasas/metabolismo , Xantomatosis Cerebrotendinosa/enzimología

RESUMEN

Cerebrotendinous xanthomatosis (CTX) is an inherited sterol storage disease associated with the accumulation of cholestanol and cholesterol in various tissues. CTX is caused by a deficiency of sterol-27-hydroxylase, a mitochondrial enzyme that oxidizes the side chain of cholesterol in the pathway leading to the formation of bile acids. In the present study we report two mutations of sterol-27-hydroxylase gene (CYP27 gene) found in Italian CTX patients. Proband T.C. is homozygous for a G-->A transition at the first nucleotide of intron 7. This mutation causes the formation of minute amounts of an abnormal mRNA, in which exon 6 joins directly to exon 8 with the skipping of exon 7. The exon 6-exon 8 junction results in a frame shift, downstream from the codon for Arg362, which generates a string of 28 novel amino acids preceding a premature termination codon. Proband C.U. is homozygous for a G-->C transversion at the last nucleotide of exon 3. This mutation, which changes the consensus sequence of the 5' donor splice site, is associated with barely detectable levels of sterol-27-hydroxylase mRNA, of normal size, in proband fibroblasts. As both mutations change the sites for two restriction enzymes, rapid methods were devised for the identification of the healthy carriers among the probands' family members and for the screening of these mutations in other CTX patients.

Asunto(s)

Sistema Enzimático del Citocromo P-450/genética , Mutación , Empalme del ARN , Esteroide Hidroxilasas/genética , Xantomatosis Cerebrotendinosa/genética , Adulto , Secuencia de Aminoácidos , Secuencia de Bases , Southern Blotting , Colestanotriol 26-Monooxigenasa , Sistema Enzimático del Citocromo P-450/metabolismo , ADN/genética , Enzimas de Restricción del ADN , Femenino , Fibroblastos/enzimología , Humanos , Masculino , Datos de Secuencia Molecular , Mutación Puntual , Polimorfismo Conformacional Retorcido-Simple , Esteroide Hidroxilasas/metabolismo

RESUMEN

An Italian subject with cerebrotendinous xanthomatosis (CTX) was found to have a partial deletion of the gene encoding the enzyme sterol 27-hydroxylase (CYP27 gene). Southern blot analysis revealed that this deletion (approximately 2 kb) spans from intron 6 to the 3' flanking (3'FLK) region, eliminating exons 7-9, the last three exons of CYP27 gene. No sterol 27-hydroxylase mRNA was detected in proband cells, either by Northern blot analysis or by reverse transcription polymerase chain reaction (PCR). This suggests that the mutant mRNA devoid of the exon encoding the whole untranslated sequence (exon 9) might be rapidly degraded in the cytoplasm. We used inverse PCR to obtain a partial sequence of the 3'FLK region of the normal CYP27 gene; this allowed us to define the mechanism underlying the deletion. The established sequence was used to design suitable primers to perform step-wise sequences of a 1.7 kb segment of the 3'FLK region of the normal gene and of the deletion joint in the CTX patient. The analysis of the sequence data indicate that the deletion might result from a complex mechanism involving two intragenic recombinations between a) two 14 nucleotide complementary sequences, one in intron 6 and the other in the 3'FLK region: and b) AT-rich complementary sequences of the 3'FLK region, and a slipped mispairing between two 6 nucleotide direct repeats, one in intron 6 and the other in the 3'FLK region. Such repeats are brought close to each other by the formation of the stem-loops induced by the two intragenic recombinations. This is the first example of CTX caused by a rearrangement of CYP27 gene.

Asunto(s)

Sistema Enzimático del Citocromo P-450/genética , Eliminación de Secuencia , Esteroide Hidroxilasas/genética , Xantomatosis Cerebrotendinosa/genética , Adulto , Secuencia de Bases , Northern Blotting , Southern Blotting , Células Cultivadas , Colestanotriol 26-Monooxigenasa , Sistema Enzimático del Citocromo P-450/química , Sistema Enzimático del Citocromo P-450/deficiencia , Femenino , Pruebas Genéticas , Heterocigoto , Humanos , Intrones/genética , Italia , Datos de Secuencia Molecular , Conformación de Ácido Nucleico , Reacción en Cadena de la Polimerasa , Mapeo Restrictivo , Análisis de Secuencia de ADN , Esteroide Hidroxilasas/química , Esteroide Hidroxilasas/deficiencia

RESUMEN

In the present study we report two novel partial deletions of the LDL-R gene. The first (FH Siracusa), found in an FH-heterozygote, consists of a 20 kb deletion spanning from the 5' flanking region to the intron 2 of the LDL-receptor gene. The elimination of the promoter and the first two exons prevents the transcription of the deleted allele, as shown by Northern blot analysis of LDL-R mRNA isolated from the proband's fibroblasts. The second deletion (FH Reggio Emilia), which eliminates 11 nucleotides of exon 10, was also found in an FH heterozygote. The characterization of this deletion was made possible by a combination of techniques such as single strand conformation polymorphism (SSCP) analysis, direct sequence of exon 10 and cloning of the normal and deleted exon 10 from the proband's DNA. The 11 nt deletion occurs in a region of exon 10 which contains three triplets (CTG) and two four-nucleotides (CTGG) direct repeats. This structural feature might render this region more susceptible to a slipped mispairing during DNA duplication. Since this deletion causes a shift of the BamHI site at the 5' end of exon 10, a method has been devised for its rapid screening which is based on the PCR amplification of exon 10 followed by BamHI digestion. FH Reggio Emilia deletion produces a shift in the reading frame downstream from Lys458, leading to a sequence of 51 novel amino acids before the occurrence of a premature stop codon (truncated receptor). However, since RT-PCR failed to demonstrate the presence of the mutant LDL-R mRNA in proband fibroblasts, it is likely that the amount of truncated receptor produced in these cells is negligible.

Asunto(s)

Mutación del Sistema de Lectura , Hiperlipoproteinemia Tipo II/genética , Receptores de LDL/genética , Eliminación de Secuencia , Adulto , Alelos , Secuencia de Bases , Células Cultivadas , Niño , Preescolar , Clonación Molecular , Análisis Mutacional de ADN , Replicación del ADN , Desoxirribonucleasa BamHI , Femenino , Fibroblastos/patología , Heterocigoto , Humanos , Hiperlipoproteinemia Tipo II/etnología , Hiperlipoproteinemia Tipo II/patología , Italia/epidemiología , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Polimorfismo Conformacional Retorcido-Simple , Receptores de LDL/deficiencia , Secuencias Repetitivas de Ácidos Nucleicos , Repeticiones de Trinucleótidos

RESUMEN

A novel point mutation of the LDL-receptor gene was found in an Italian patient with homozygous familial hypercholesterolemia. The SSCP analysis of the promoter and of 16 out of the 18 exons of the LDL-receptor gene was negative, suggesting that the mutation might be located in the region of the gene encompassing exons 14 and 15, a region that had not been amenable to polymerase chain reaction (PCR) amplification from genomic DNA. This region was amplified from cDNA by reverse transcription PCR (RT-PCR). RT-PCR of proband cDNA generated three fragments of 800, 600, and 550 bp, respectively, as opposed to a single 720 bp fragment obtained from control cDNA. The sequence of these fragments showed that: i) in the 800-bp fragment exon 14 continued with the 5' end of intron 15 (90 nucleotides), which in turn was followed by exon 16; ii) in the 600-bp fragment exon 14 was followed by the 5' end of exon 15 (50 nucleotides), which continued with exon 16; iii) in the 550-bp fragment exon 14 joined directly to exon 16. These abnormally spliced mRNAs resulted from a G-->A transition at the +1 nucleotide of intron 15, which changed the invariant GT dinucleotide of the 5' donor splice site. That was associated with the activation of two cryptic donor splice sites in intron 15 and exon 15, respectively, and the use of an alternative splicing leading to the skipping of exon 15. Northern blot analysis showed that the overall content of these aberrantly spliced mRNAs in proband fibroblasts was one-fourth that found in control cells. These abnormally spliced mRNAs are predicted to encode three abnormal receptor proteins: the first would contain an insertion of 30 novel amino acids; the second would be a truncated protein of 709 amino acids; the third would be devoid of the 57 amino acids of the O-linked sugar domain. Ligand blot experiments indicated that the amount of LDL-receptor present in proband's fibroblasts was approximately one-tenth that found in control cells.

Asunto(s)

Hiperlipoproteinemia Tipo II/genética , Mutación Puntual , Empalme del ARN , Receptores de LDL/genética , Secuencia de Bases , Northern Blotting , Southern Blotting , Niño , ADN Complementario/química , Exones , Humanos , Radioisótopos de Yodo , Italia , Lipoproteínas LDL/metabolismo , Masculino , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Polimorfismo Conformacional Retorcido-Simple , Regiones Promotoras Genéticas , ARN Mensajero/metabolismo , ADN Polimerasa Dirigida por ARN , Receptores de LDL/metabolismo

RESUMEN

In this study, we report four new partial deletions of the LDL-receptor (LDL-R) gene discovered during a survey of 326 Italian patients with familial hypercholesterolemia (FH). All deletions were found in FH heterozygotes whose LDL-R activity in skin fibroblasts ranged from 52% to 43% of the values found in control cells. The size and boundaries of the deletions were defined by Southern blotting and, in some cases, by polymerase chain reaction (PCR) amplification of genomic DNA. The sequence of the deletion joint was performed after the reverse transcription and PCR amplification of the appropriate regions of LDL-R mRNA. FHMassa is a 12-kilobase deletion spanning from intron 2 to intron 10. RT-PCR showed that the mutant allele is transcribed into one major and two minor mRNAs. In the most abundant mRNA species, exon 2 joins exon 11, as expected from DNA analysis. In one minor mRNA, which was sequenced, exon 2 joins exon 13, with exons 11 and 12 skipped as a result of an alternative splicing. FHGenova is a 4-kb deletion spanning from intron 10 to intron 12 and eliminating exons 11 and 12. FHRoma is a 4.7-kb deletion spanning from the 5' end of intron 12 to the middle of intron 14 and eliminating exons 13 and 14. This deletion differs in size from the previously described deletion (FHChieti/Macerata), which is located in the same region of the LDL-R gene but is smaller (3.7 kb).(ABSTRACT TRUNCATED AT 250 WORDS)

Asunto(s)

Eliminación de Gen , Hiperlipoproteinemia Tipo II/genética , Receptores de LDL/genética , Adulto , Secuencia de Bases , Mapeo Cromosómico , ADN Complementario , Femenino , Haplotipos , Humanos , Hiperlipoproteinemia Tipo II/metabolismo , Italia , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , ARN Mensajero/genética

RESUMEN

During a survey of the mutations of the low density lipoprotein receptor (LDL-R) gene in Italian patients with familial hypercholesterolemia (FH), we identified a novel point mutation, that creates a new EcoRI site at the 5' end of exon 7, in a heterozygous FH subject (FH-100). The sequence of a cDNA fragment encompassing exon 7 showed the presence of a G-->T transversion in codon 297; this created a new EcoRI site and produced a missense mutation, leading to a Cys297-->Phe substitution in repeat A of the epidermal growth factor (EGF) precursor homology domain of LDL-R. Since the substitution of Cys297 disrupts the intracellular transport of the LDL-R protein, as previously demonstrated by site-directed mutagenesis, we suggest that this mutation is the cause of FH in the FH-100 proband. We screened the DNA of 303 Italian FH patients by amplification of exon 7 from genomic DNA followed by digestion with EcoRI or by Southern blotting. Two individuals (FH-64 and FH-127) were found to be carriers of the Cys297-->Phe mutation. Restriction fragment length polymorphism analysis demonstrated that, in two kindreds (FH-64 and FH-100), the haplotype in linkage with the Cys297-->Phe mutation was the same, suggesting the presence of a common ancestor. The Cys297-->Phe mutation has been designated FHTrieste after the name of the city in Northern Italy from which probands FH-100 and FH-127 originate.

Asunto(s)

Cisteína , Hiperlipoproteinemia Tipo II/genética , Fenilalanina , Mutación Puntual , Receptores de LDL/genética , Secuencia de Bases , Southern Blotting , ADN/análisis , Análisis Mutacional de ADN , Exones/genética , Femenino , Humanos , Italia , Masculino , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa

RESUMEN

An analysis of LDL-receptor gene was performed on an Italian patient with heterozygous familial hypercholesterolemia. Restriction enzyme analysis showed that the proband was heterozygous for a deletion of 4.5 kb spanning the 5' end of exon 13 (45 nucleotide residues) to intron 15. Amplification of genomic DNA, using polymerase chain reaction (PCR), followed by direct sequencing, showed that this deletion was identical to the one reported by Lehrman et al. (1986. Proc. Natl. Acad. Sci. 83: 3679-3683). As only the normal LDL-receptor mRNA was detectable in proband fibroblasts by Northern blot, we used reverse transcription-PCR to amplify the mutant mRNA using primers complementary to exon 6 (sense) and exon 18 (antisense). The amplification of control cDNA resulted in a single fragment of 1725 nucleotides containing the normal sequence. The amplification of cDNA from the proband produced the 1725-nucleotide fragment (as in the control) and three additional fragments (F1, F2, and F3) of smaller size. The direct sequence showed that in the F1 fragment exon 12 was joined to exon 16; in the F2 fragment exon 12 was joined to exon 17; and in the F3 fragment exon 11 was joined to exon 16. Thus, the deletion-bearing allele generated three mRNAs, two of which resulted from alternative splicings leading to the skipping of exons 16 and 12, respectively. It is expected that the translation of these mutant mRNAs will generate three aberrant proteins, the synthesis of which should be negligible in view of the very low content of the corresponding mRNAs.

Asunto(s)

Empalme Alternativo , Eliminación de Gen , Hiperlipoproteinemia Tipo II/genética , ARN Mensajero/genética , Receptores de LDL/genética , Secuencia de Bases , Northern Blotting , Southern Blotting , Cartilla de ADN , ADN Complementario , Femenino , Heterocigoto , Humanos , Lactante , Italia , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa

RESUMEN

We report the case of a patient with prolymphocytic leukemia in whom a lengthy survival of 5 years was observed after treatment with splenic irradiation and chemotherapy. The patient obtained a surprising improvement with a significant reduction in the absolute count of the prolymphocytes and considerable reduction in splenomegaly after 3 months' therapy with interferon alpha.

Asunto(s)

Factores Inmunológicos/uso terapéutico , Interferón-alfa/uso terapéutico , Leucemia Prolinfocítica/terapia , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Recuento de Células Sanguíneas/efectos de los fármacos , Transfusión Sanguínea , Clorambucilo/administración & dosificación , Terapia Combinada , Ciclofosfamida/administración & dosificación , Epirrubicina/administración & dosificación , Humanos , Hiperesplenismo/etiología , Hiperesplenismo/terapia , Interferón alfa-2 , Leucemia Prolinfocítica/complicaciones , Leucemia Prolinfocítica/tratamiento farmacológico , Leucemia Prolinfocítica/radioterapia , Masculino , Prednisona/administración & dosificación , Proteínas Recombinantes , Esplenomegalia/etiología , Esplenomegalia/radioterapia , Vincristina/administración & dosificación